Document Classification

Section Type: RESULTS

Text: In the fourth, fifth and sixth cycles, mean bleeding days in the 50-mg group (0. 86, 1. 05 and 0. 62, respectively) were significantly less than those in the 25-mg group (3. 5, 2. 87 and 2. 4 respectively) ; mean no bleeding days in the 50-mg group (26. 07, 25. 95 and 26. 11, respectively) were significantly more than those in the 25-mg group (22. 93, 23. 23 and 23. 51, respectively), and the percentage of women who had no bleeding in a 28-day study cycle in the 50-mg group (22. 3 %, 25 % and 21. 1 %, respectively) was significantly more than those in the 25-mg group (2. 6 %, 3. 9 % and 3. 9 %, respectively).